Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1992-02-24
1993-06-01
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
558169, A61K 31685, C07F 910
Patent
active
052159736
ABSTRACT:
Monohydrate 1,2-di-O-acetyl-glycero-phosphoryl-choline in optically active and racemic form, processes for their preparation and pharmaceutical compositions containing them as the active principle for treating cerebral involutions of the aged and for treating dislipidemia and hyperlipoproteinemia.
REFERENCES:
patent: 3687932 (1972-08-01), Nakamachi et al.
patent: 4607046 (1986-08-01), Morita et al.
Robert H. Pearson, "The Molecular Structure of Lecithin Dihydrate", Nature vol. 281 pp. 499-501, 1987.
N. H. Phuong, et al. "Chimie Organique". C.R. Acad. Sc. Paris vol. 283, pp. 323-325, 1976.
N. H. Phuong, et al. "Chimie Organique". C.R. Acad. Sc. Paris vol. 283, pp. 229-231, 1976.
Etsuo Hasegawa, et al. "A Convenient Synthesis of Mixed-Acid Glycerophosphocholines". Journal of Synthetic Organic Chemistry No. 1, pp. 60-62, 1986.
Ambrose Michael G.
Lee Mary C.
Magis Farmaceutici S.p.A.
LandOfFree
Optically active and racemic hydrated diacetylesters of .alpha.- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Optically active and racemic hydrated diacetylesters of .alpha.-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Optically active and racemic hydrated diacetylesters of .alpha.- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1814534